Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Subcutaneous immunoglobulin appears to be an effective treatment alternative to intravenous immunoglobulin for patients with chronic inflammatory demyelinating polyneuropathy.

Subcutaneous Immunoglobulin in Chronic Inflammatory Demyelinating Polyneuropathy